|
Zimmer Biomet Holdings, Inc. (ZMH) |
|
|
|
|
|
EARNINGS REPORT by CSIMarket
Income Tumbles by -88.54 %, Sales very Strong
Zimmer Biomet Holdings, Inc announced third quarter 2015 operating surplus of $116 millions, revenue expected to reach $4,580 millions, for the Year
_scan_pd.jpg "Tomography_(CAT)_scan_pd") Zimmer Biomet Holdings, Inc announced earnings per share of $0.11 and Sales of $1.17 billions in the third quarter 2015, Company's income fell sharply by -88.54 % per share, versus $0.96 eps, earned in the same quarter a year ago, although Zimmer Biomet Holdings, Inc saw it's Sales rise by 59.33 % in the same period. In contrast to the second quarter 2015 Sales surged by 50.92 % from $1.17 billions and EPS turn positive from $ -0.91 per share. Profits improved in following segments: Americas 75.85%, Asia Pacific 39.61%, Europe 38.47%. Net income of $22.200 millions in the third quarter 2015 fell by -86.59 % from $165.500 millions in the corresponding period a year before. Company's net margin was effected by $123 million asset impairment, other weise Zimmer Biomet Holdings, Inc would have been more profitable in the third quarter 2015. Zimmer Biomet Holdings, Inc shifted it's focus on improving sales in the third quarter 2015, as a result net margin eased to 1.26%. Company provided revenue outlook in the range between, $4,580 millions and $4,580 millions. Zimmer Biomet Holdings, Inc is expected to report next financial results on April 30, 2021.
|
Recently Reported Results |
![TSF2_By_TSFgrupo1_(Own_work)__[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Common](../news/img/semiconductors/TSF2_By_TSFgrupo1_(Own_work)__[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Common.jpg "TSF2_By_TSFgrupo1_(Own_work)__[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Common")
Inphi Corp
Zimmer Biomet Holdings, Inc announced earnings per share of $0.11 and Sales of $1.17 billions in the third quarter 2015, Company's income fell sharply by -88.54 % per share, versus $0.96 eps, earned in the same quarter a year ago, although Zimmer Biomet Holdings, Inc saw it's Sales rise by 59.33 % in the same period.
In contrast to the third quarter Sales increased by 3.79 % from $180.69 millions and increased losses from $-0.07 per share.
Inphi Corp reported net loss of $-59.74 millions and Sales of $682.95 millions for the fiscal year 2020.
Company has decreased loss per share to $-1.20 from $-1.61 in the previous fiscal year, while Sales surged by 86.79 % from $365.64 millions a year ago.
IPHI stock quotes, charts, profile
Growth Rates, Profitability, PE
|
![Supercenter_Theonlysilentbob_at_en.wikipedia__[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Common](../news/img/shopping/Supercenter_Theonlysilentbob_at_en.wikipedia__[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Common.jpg "Supercenter_Theonlysilentbob_at_en.wikipedia__[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Common")
Retail Sales
Good news came from the Retail sales report, as it shows improvement after months of deterioration, as rising gasoline prices weren’t enough to choke off U.S. consumers’ demand for cars, clothing and other goods, government data showed.
|
![closeup_By_Jean-Etienne_Minh-Duy_Poirrier_from_Bruxelles_Belgium_[CC-BY-SA-2.0_(http_creativecommons.org_licenses_by-sa_2.0)]_via_Wikimedia_Commons](../news/img/healthcare/closeup_By_Jean-Etienne_Minh-Duy_Poirrier_from_Bruxelles_Belgium_[CC-BY-SA-2.0_(http_creativecommons.org_licenses_by-sa_2.0)]_via_Wikimedia_Commons.jpg "closeup_By_Jean-Etienne_Minh-Duy_Poirrier_from_Bruxelles_Belgium_[CC-BY-SA-2.0_(http_creativecommons.org_licenses_by-sa_2.0)]_via_Wikimedia_Commons")
Cardiff Oncology Inc
For the financial fourth quarter of 2020 Cardiff Oncology Inc decreased loss at $-0.18 per share, compared to results of $-0.49 per share a year ago quarter, In the previous quarter company realized $-0.19 per share.
Sales deteriorated by -12.57% from $0.14 millions in preceding quarter, improved from $-0.19 per share.
Cardiff Oncology Inc reported net loss of $-22.57 millions and Sales of $0.37 millions for the fiscal year 2020.
Company has decreased loss per share to $-1.08 from $-2.80 in the previous fiscal year, while Sales surged by 49.61 % from $0.24 millions a year ago.
CRDF stock quotes, charts, profile
Growth Rates, Profitability, PE
|
![Red_pill_wikipedia_By_FML_(Own_work)_[CC-BY-SA-2.5_(http_creativecommons.org_licenses_by-sa_2.5)]_via_Wikimedia_Commons](../news/img/healthcare/Red_pill_wikipedia_By_FML_(Own_work)_[CC-BY-SA-2.5_(http_creativecommons.org_licenses_by-sa_2.5)]_via_Wikimedia_Commons.jpg "Red_pill_wikipedia_By_FML_(Own_work)_[CC-BY-SA-2.5_(http_creativecommons.org_licenses_by-sa_2.5)]_via_Wikimedia_Commons")
Neophotonics Corp
In the fourth quarter of 2020 earnings season Neophotonics Corp posted a loss of $-0.23 per share compared to $0.04 a year ago and increased losses from $-0.10 per share from the previous quarter.
Sales faded by -34.02% to $68.19 millions from $103.36 millions in the same quarter a year ago and sequentially Sales Tumbled by -33.4% from $102.40 millions.
Neophotonics Corp reported net loss of $-4.37 millions and Sales of $371.16 millions for the fiscal year 2020.
Company has decreased loss per share to $-0.09 from $-0.36 in the previous fiscal year, while Sales increased by 4.02 % from $356.80 millions a year ago.
NPTN stock quotes, charts, profile
Growth Rates, Profitability, PE
|
![NASDAQ_studio_By_Luis_Villa_del_Campo__[CC-BY-SA-2.0_(http_creativecommons.org_licenses_by-sa_2.0)]_via_Wikimedia_Commons](../news/img/stocks/NASDAQ_studio_By_Luis_Villa_del_Campo__[CC-BY-SA-2.0_(http_creativecommons.org_licenses_by-sa_2.0)]_via_Wikimedia_Commons.jpg "NASDAQ_studio_By_Luis_Villa_del_Campo__[CC-BY-SA-2.0_(http_creativecommons.org_licenses_by-sa_2.0)]_via_Wikimedia_Commons")
Piper Sandler Companies
In the fourth quarter of 2020 Piper Sandler Companies eps of $2.66 per share compared to $0.00 a year ago and eps more than doubled by 240.72 % from $0.78 per share from the previous quarter.
Sales remained unchanged to $409.14 millions from $0.00 millions in the same quarter a year ago and sequentially Sales surged by 33.19 % from $307.17 millions.
In the fiscal year 2020, Piper Sandler Companies reported Sales of $1.25 billions and net income of $49.36 millions.
Income per share faded by -64.63 % to $2.72 per share from $7.69 in the previous fiscal year, while Sales surged by 48.02 % from $846.30 millions a year ago.
PIPR stock quotes, charts, profile
Growth Rates, Profitability, PE
|
![Montage_By_Michael_Schmahl_(Own_work)__[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Commons](../news/img/construction/Montage_By_Michael_Schmahl_(Own_work)__[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Commons.jpg "Montage_By_Michael_Schmahl_(Own_work)__[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Commons")
Construction Spending
The rate of growth in construction outlays accelerated due to increase in .
|
![Loxley_Farm_Market_Produce_By_Infrogmation_of_New_Orleans_[CC-BY-SA-3.0_(http_creativecommons.org_licensesby-sa3.0)]_via_Wikimedia_Commons](../news/img/food/Loxley_Farm_Market_Produce_By_Infrogmation_of_New_Orleans_[CC-BY-SA-3.0_(http_creativecommons.org_licensesby-sa3.0)]_via_Wikimedia_Commons.JPG "Loxley_Farm_Market_Produce_By_Infrogmation_of_New_Orleans_[CC-BY-SA-3.0_(http_creativecommons.org_licensesby-sa3.0)]_via_Wikimedia_Commons")
Consumer Price Index
|
Employment Report
|
Apollo Endosurgery inc
Apollo Endosurgery Inc announced earnings per share of $-0.14 and Sales of $12.83 millions in the fourth quarter of 2020 earnings season, Company's lost money per share, versus $-0.34 eps, earned in the same quarter a year ago, although Apollo Endosurgery Inc saw its Sales rise by 7.26% in the same period.
In contrast to the third quarter Sales increased by 0.27 % from $12.83 millions and increased losses from $-0.11 per share.
Apollo Endosurgery Inc reported net loss of $-22.61 millions and Sales of $42.05 millions for the fiscal year 2020.
Company has decreased loss per share to $-0.99 from $-1.27 in the previous fiscal year, while Sales fell by -17.09 % from $50.71 millions a year ago.
APEN stock quotes, charts, profile
Growth Rates, Profitability, PE
|
Whiting Petroleum Corp
Despite very strong Sales growth of 125.93% year on year to $859.91 millions in the financial period ending Dec 31 2020, company faced turn a round at $43.73.
compared to previous quarter EPS turn positive from $-0.21 per share and Sales doubled by 128.77 % from $375.89 millions.
Apollo Endosurgery Inc reported net loss of $-22.61 millions and Sales of $42.05 millions for the fiscal year 2020.
Company has decreased loss per share to $-0.99 from $-1.27 in the previous fiscal year, while Sales fell by -17.09 % from $50.71 millions a year ago.
WLL stock quotes, charts, profile
Growth Rates, Profitability, PE
|
![Commercial_Street_By_Mtaylor848_(Own_work)_[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Commons](../news/img/banks/Commercial_Street_By_Mtaylor848_(Own_work)_[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Commons.jpg "Commercial_Street_By_Mtaylor848_(Own_work)_[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Commons")
Nelnet Inc
Nelnet Inc delivered very strong results in the financial fourth quarter of 2020, where Revenues soared by 96.25% to $539.89 millions, while company's earnings per share soared by 473.87 % to $6.10 per share, from the same quarter a year ago.
In contrast to the third quarter Revenues surged by 72.69 % from $312.64 millions and eps more than doubled by 227.8 % from $1.86 per share.
In the fiscal year 2020, Nelnet Inc reported Revenues of $1.34 billions and net income of $349.63 millions.
Eps surged by 154.8 % to $9.02 per share from $3.54 in the previous fiscal year, while Revenues improved by 28.32 % from $1.04 billions a year ago.
NNI stock quotes, charts, profile
Growth Rates, Profitability, PE
|
![pills_rapid_release_pills_By_Katy_Warner_from_Orlando_FL_USA_[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Commons](../news/img/healthcare/pills_rapid_release_pills_By_Katy_Warner_from_Orlando_FL_USA_[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Commons.jpg "pills_rapid_release_pills_By_Katy_Warner_from_Orlando_FL_USA_[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Commons")
Collegium Pharmaceutical Inc
Despite very strong Sales growth of 104.74% year on year to $149.34 millions in the fourth quarter of 2020, company faced earnings turn positive at $0.20.
compared to previous quarter income faded by -37.5% from $0.32 per share and Sales surged by 35.57 % from $110.16 millions.
Collegium Pharmaceutical Inc reported earnings of $26.75 millions and Sales of $440.20 millions for the fiscal year 2020.
Company reported earnings per share of $0.76 compared to $-0.68 in the previous fiscal year, while Sales surged by 48.36 % from $296.70 millions a year ago.
COLL stock quotes, charts, profile
Growth Rates, Profitability, PE
|
Intercept Pharmaceuticals inc
Intercept Pharmaceuticals Inc announced earnings per share of $-1.56 and Sales of $79.52 millions in the fourth quarter of 2020, Company's decreased loss per share, versus $-2.99 eps, earned in the same quarter a year ago, although Intercept Pharmaceuticals Inc saw its Sales rise by 16.46% in the same period.
Earnings deteriorated from the preceding quarter from $-2.01 per share, Sales increased by 4.71 % from $79.52 millions.
Intercept Pharmaceuticals Inc reported net loss of $-274.88 millions and Sales of $312.69 millions for the fiscal year 2020.
Company has decreased loss per share to $-8.34 from $-10.89 in the previous fiscal year, while Sales improved by 24.08 % from $252.00 millions a year ago.
ICPT stock quotes, charts, profile
Growth Rates, Profitability, PE
|
|
Gran Tierra Energy Inc
In the most recent fiscal period Gran Tierra Energy Inc loss increased of $-0.13 per share compared to $0.07 a year ago and improved from $-0.29 per share from the previous quarter.
Sales faded by -44.11% to $64.32 millions from $115.08 millions in the same quarter a year ago and sequentially Sales improved by 21.04 % from $53.14 millions.
Gran Tierra Energy Inc reported net loss of $-777.97 millions and Sales of $237.71 millions for the fiscal year 2020.
Company recorded loss per share of $-2.12 compared to $0.10 in the previous fiscal year, while Sales Tumbled by -57.46 % from $558.79 millions a year ago.
GTE stock quotes, charts, profile
Growth Rates, Profitability, PE
|
|
|
|
|
|
|
